Medipharm Labs Liabilities 2024

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Medipharm Labs's Liabilities

Medipharm Labs's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Medipharm Labs's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Medipharm Labs's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Medipharm Labs's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Medipharm Labs’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Medipharm Labs stock

What is the level of liabilities of Medipharm Labs this year?

Medipharm Labs has a debt balance of 10.93 M CAD this year.

What were the liabilities of Medipharm Labs compared to the previous year?

The liabilities of Medipharm Labs have increased by 15.07% increased compared to the previous year.

What are the consequences of high debt for investors of Medipharm Labs?

High liabilities can pose a risk for investors of Medipharm Labs, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Medipharm Labs?

Low liabilities mean that Medipharm Labs has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Medipharm Labs affect the company?

An increase in liabilities of Medipharm Labs can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Medipharm Labs affect the company?

A decrease in the liabilities of Medipharm Labs can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Medipharm Labs?

Some factors that can influence the liabilities of Medipharm Labs include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Medipharm Labs so important for investors?

The liabilities of Medipharm Labs are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Medipharm Labs take to modify the liabilities?

To change its liabilities, Medipharm Labs can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 7/8/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 7/8/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 7/8/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.